Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Epredia™ Lab Vision™ ALK (Anaplastic Lymphoma Kinase)/p80 Ab-1 Mouse Monoclonal Antibody, 7mL

Obtain accurate, reproducible results in immunohistochemistry experiments with Epredia™ ALK (Anaplastic Lymphoma Kinase)/p80 Ab-1, Mouse Monoclonal Antibody.

Supplier:  Epredia™ MS1104S1

 View more versions of this product

Catalog No. MS1104S1


Description

Description

ALK/p80 is a hybrid of the anaplastic lymphoma kinase (ALK) gene and the nucleophosmin (NPM) gene resulting from the t(2;5)(p23;q35) translocation found in a third of large cell lymphomas.

Host Species: Mouse

Clone: 5A4

Isotype: IgG1

Species Reactivity: Human. Others not tested.

Epitope: aa 419-520 (tyrosine kinase domain)

Immunogen: Recombinant protein corresponding to a region which spans the tyrosine kinase catalytic domain and part of the C-terminus of the NPM-ALK transcript (419-520aa)

Molecular Weight: 80kDa

Positive Control: Anaplastic lymphoma

Cellular Localization: Cytoplasmic and/or nuclear

Recommended for:

  • Immunohistochemistry (Formalin/paraffin)
  • Western Blotting (Not recommended)
Specifications

Specifications

ALK (Anaplastic Lymphoma Kinase)/p80 Ab-1
Monoclonal
Unconjugated
Recombinant protein corresponding to a region which spans the tyrosine kinase catalytic domain and part of the C-terminus of the NPM-ALK transcript (419-520aa)
IVD
Primary
Concentrated
Immunohistochemistry (Paraffin)
5A4
Mouse
500 μL
Oncogenesis
Human
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.